Hormonal contraception and post-menopausal hormonal therapy.
Material type: TextSeries: IARC monographs on the evaluation of carcinogenic risks to humans ; v. 72Publication details: Lyon : International Agency for Research on Cancer, 1999. Description: 660 pISBN: 928321272XISSN: 1017-1606Subject(s): Contraceptives, Oral, Combined -- adverse effects | Progestins -- adverse effects | Estrogen replacement therapy -- adverse effects | Risk assessment | Epidemiologic studies | Case-control studies | Cohort studies | Chemical Toxicology and CarcinogenicityNLM classification: QV 177 99HOItem type | Current library | Collection | Call number | Copy number | Status | Date due | Barcode |
---|---|---|---|---|---|---|---|
Books | WHO HQ READING-RM | DC-IARC | DC.IARC SERIAL (Browse shelf(Opens below)) | 1 | Available | 00062715 | |
Books | WHO HQ BORROWABLE-COLL-STACKS | QV 177 99HO (Browse shelf(Opens below)) | 2 | Withdrawn | 00062716 |
Browsing WHO HQ shelves, Shelving location: BORROWABLE-COLL-STACKS Close shelf browser (Hides shelf browser)
QV 177 96CO Contraceptive research and development : | QV 177 97ES The Essentials of contraceptive technology: | QV 177 97ES-1 Eléments de la technologie de la contraception : | QV 177 99HO Hormonal contraception and post-menopausal hormonal therapy. | QV 18 70WH Clinical pharmacology scope, organization, training : | QV 18 80KE Drugs and solutions : | QV 18 89TH La Thérapeutique en prescriptions : |
DC.IARC
WHODOC
WHO monograph
4
There are no comments on this title.